Telehealth corporate’s semaglutide emails in TGA sights
Eucalyptus Health says the emails to patients complied with advertising rules.
The TGA is “making inquiries” after GP telehealth corporate Eucalyptus Health emailed patients to say its doctors could now prescribe Ozempic (semaglutide) for weight loss.
The four-year-old company — which has raised at least $60 million from investors — runs multiple telehealth websites, including men’s health site Pilot and women’s health site Juniper.
